Cargando…

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Elevated serum levels of hepatocyte growth factor (HGF) and high tumor expression of c-Met are both indicators of poor overall survival from ovarian cancer (OVCA). In the present study, we evaluated the role of the HGF signaling pathway in OVCA cell line chemoresistance and OVCA patient overall surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	MARCHION, DOUGLAS C., BICAKU, ELONA, XIONG, YIN, ZGHEIB, NADIM BOU, SAWAH, ENTIDHAR AL, STICKLES, XIAOMANG BA, JUDSON, PATRICIA L., LOPEZ, ALEX S., CUBITT, CHRISTOPHER L., GONZALEZ-BOSQUET, JESUS, WENHAM, ROBERT M., APTE, SACHIN M., BERGLUND, ANDERS, LANCASTER, JOHNATHAN M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536335/ https://www.ncbi.nlm.nih.gov/pubmed/23467907 http://dx.doi.org/10.3892/or.2013.2329

Ejemplares similares

BAD-mediated apoptotic pathway is associated with human cancer development
por: STICKLES, XIAOMANG B, et al.
Publicado: (2015)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
por: Bansal, Nisha, et al.
Publicado: (2012)

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
por: Bicaku, E, et al.
Publicado: (2012)

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
por: CHEN, NING, et al.
Publicado: (2014)

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers
por: Chon, Hye Sook, et al.
Publicado: (2017)

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes
por: Saeed-Vafa, Daryoush, et al.
Publicado: (2021)

Association between Obesity, Surgical Route, and Perioperative Outcomes in Patients with Uterine Cancer
por: Al Sawah, Entidhar, et al.
Publicado: (2018)

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer
por: Becker, Marc A., et al.
Publicado: (2016)

Endometriosis and ovarian cancer risk, an epigenetic connection
por: Brunty, Sarah, et al.
Publicado: (2020)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
por: Robertson, Sharon E., et al.
Publicado: (2023)

Recurrent Neuroendocrine Tumor of the Cervix Presenting With Ectopic Cushing’s Syndrome
por: Rico, Jeffrey G, et al.
Publicado: (2022)

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors
por: Molife, L Rhoda, et al.
Publicado: (2014)

Primary Retroperitoneal Melanoma Presented in a Rare Extracutaneous Site for Malignant Melanoma
por: Alsharedi, Mohamed, et al.
Publicado: (2016)

Peritoneal Modulators of Endometriosis-Associated Ovarian Cancer
por: Brunty, Sarah, et al.
Publicado: (2021)

Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer
por: Koc, Zeynep C., et al.
Publicado: (2023)

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
por: Yang, Bangkun, et al.
Publicado: (2016)

Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center
por: Judson, Patricia L., et al.
Publicado: (2016)

The acid–base and redox properties of menaquinone MK-4, MK-7, and MK-9 (vitamin K(2)) in DMPC monolayers on mercury
por: Dharmaraj, Karuppasamy, et al.
Publicado: (2020)

Immunomodulatory biomaterials on chemokine signaling in wound healing
por: Apte, Anisha, et al.
Publicado: (2023)

Synchro Clock MkIV
por: Odier, P, et al.
Publicado: (2010)

Crucial Roles of the Protein Kinases MK2 and MK3 in a Mouse Model of Glomerulonephritis
por: Guess, Adam J., et al.
Publicado: (2013)

Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2
por: Gurgis, FMS, et al.
Publicado: (2015)

Cooperative and distinct functions of MK2 and MK3 in the regulation of the macrophage transcriptional response to lipopolysaccharide
por: Ehlting, Christian, et al.
Publicado: (2019)

GROWTH CHARACTERISTICS OF MONKEY KIDNEY CELL STRAINS LLC-MK(1), LLC-MK(2), AND LLC-MK(2)(NCTC-3196) AND THEIR UTILITY IN VIRUS RESEARCH
por: Hull, R. N., et al.
Publicado: (1962)

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
por: Brana, I, et al.
Publicado: (2014)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer
por: Howard, Candace M, et al.
Publicado: (2021)

How nephrotoxic is carboplatin?
por: Hardy, J. R., et al.
Publicado: (1990)

Carboplatin binding to histidine
por: Tanley, Simon W. M., et al.
Publicado: (2014)

Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
por: Harries, M, et al.
Publicado: (2004)

Heat transfer at a sapphire – indium interface in the 30 mK – 300 mK temperature range
por: Liberadzka, J, et al.
Publicado: (2017)

Influence of CdS Morphology on the Efficiency of Dye-Sensitized Solar Cells
por: Alkuam, Entidhar, et al.
Publicado: (2018)

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
por: Dechaphunkul, Tanadech, et al.
Publicado: (2011)

Peering inside a cough or sneeze to explain enhanced airborne transmission under dry weather
por: Liu, Kai, et al.
Publicado: (2021)

Carboplatin and renal function in children.
por: Stevens, M. C., et al.
Publicado: (1991)

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Carboplatin-Induced Hypersensitivity Reaction
por: Potolidis, Evangelos, et al.
Publicado: (2012)

Hypersensitivity to Carboplatin in Children with Malignancy
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Aryl hydrocarbon receptor inhibits inflammation in DSS-induced colitis via the MK2/p-MK2/TTP pathway
por: Wang, Qimeng, et al.
Publicado: (2018)

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.
por: Rankin, E. M., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_8410477jd88ao5g7vm4os9mbih